ABLOK

Brand name authorized in: Brazil

Active ingredients

The drug ABLOK contains one active pharmaceutical ingredient (API):

1 Atenolol
UNII 50VV3VW0TI - ATENOLOL

Atenolol is a beta-blocker which is beta1-selective, (i.e. acts preferentially on beta1-adrenergic receptors in the heart). Atenolol is without intrinsic sympathomimetic and membrane-stabilising activities and as with other beta-blockers, has negative inotropic effects.

Read about Atenolol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Atenolol
C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AB Beta blocking agents, selective
Discover more medicines within C07AB03

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
BR
Câmara de Regulação do Mercado de Medicamentos
Identifier(s): 504100101113419, 504100102111411, 504100103116415, 504114070052003, 504114070052103, 504114070052203, 504114100052403, 504114100052503, 504114100052603